25 Stocks Moving in Thursday's Pre-Market Session

Author: Lisa Levin | June 24, 2021 07:00am

Gainers

Marin Software Incorporated (NASDAQ:MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
India Globalization Capital, Inc. (NYSE:IGC) rose 37.8% to $2.04 in pre-market trading. IGC said it has completed the final Cohort of its Phase 1 Clinical trial on Alzheimer’s patients.
GTT Communications, Inc. (NYSE:GTT) rose 37.5% to $3.41 in pre-market trading after surging over 13% on Wednesday.
DHI Group, Inc. (NYSE:DHX) shares rose 17.6% to $3.28 in pre-market trading after the company announced it will add $12 million to its stock buyback, increasing the overall buyback to $20 million.
Arcus Biosciences, Inc. (NYSE:RCUS) shares rose 15% to $26.90 in pre-market trading after the company disclosed data from the first interim analysis of the three-arm randomized Phase 2 ARC-7 study.
Applied Genetic Technologies Corporation (NASDAQ:AGTC) shares rose 14.2% to $4.76 in pre-market trading after the company announced plans to release 12-month data for adult patients and low-dose pediatric patients in its Phase 1/2 clinical Achromatopsia trials on Thursday, June 24, 2021.
iBio, Inc. (NYSE:IBIO) rose 12.2% to $1.75 in pre-market trading after the company reported Q3 results.
Orphazyme A/S (NASDAQ:ORPH) rose 10% to $8.18 in pre-market trading. Orphazyme, which recently faced a regulatory setback, said the Goldman Sachs Group briefly increased its stake in Orphazyme above 5%.
Uxin Limited (NASDAQ:UXIN) rose 8.8% to $4.07 in pre-market trading after gaining over 7% on Wednesday.
Franklin Street Properties Corp. (NYSE:FSP) rose 8.4% to $5.69 in pre-market trading after the company reported a $50-million buyback.
Sprinklr, Inc. (NYSE:CXM) shares rose 8.2% to $19.04 in pre-market trading. Sprinklr shares gained 10% on Wednesday after the company priced its IPO at $16 per share.
Tower Semiconductor Ltd. (NASDAQ:TSEM) rose 7.7% to $29.42 in pre-market trading. STMicroelectronics and Tower Semiconductor announced an agreement by which STMicroelectronics will bring Tower Semiconductor on board 300mm analog and power fab under construction in Italy.
Sundial Growers Inc. (NASDAQ:SNDL) rose 6% to $1.06 in pre-market trading after surging over 12% on Wednesday.
Clover Health Investments, Corp. (NASDAQ:CLOV) rose 5.8% to $14.63 in pre-market trading after gaining around 10% on Wednesday.
Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares rose 5.7% to $1.27 in pre-market trading after declining 4% on Wednesday.
Moxian, Inc. (NASDAQ:MOXC) rose 5.4% to $21.17 in pre-market trading after jumping 22% on Wednesday.
Property Solutions Acquisition Corp. (NASDAQ:PSAC) rose 5.4% to $15.70 in pre-market trading after climbing over 8% on Wednesday.
FTAC Olympus Acquisition Corp. (NASDAQ:FTOC) shares rose 5% to $10.91 in pre-market trading. FTAC Olympus Acquisition’s shareholders approved proposed business combination with Payoneer.
Steelcase Inc. (NYSE:SCS) rose 3.2% to $15.00 in pre-market trading after the company reported better-than-expected Q1 results and issued Q2 guidance above estimates.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

Portage Biotech Inc. (NASDAQ:PRTG) fell 24.7% to $26.20 in pre-market trading after the company reported a proposed offering of ordinary shares.
Daqo New Energy Corp. (NYSE:DQ) fell 6.5% to $54.32 in pre-market trading after gaining around 3% on Wednesday.
Talos Energy Inc. (NYSE:TALO) shares fell 6.3% to $17.48 in pre-market trading after the company reported the pricing of secondary public offering of common stock.
ReTo Eco-Solutions, Inc. (NASDAQ:RETO) fell 5.3% to $1.25 in pre-market trading. ReTo Eco-Solutions shares gained around 13% on Wednesday after the company announced a $43.7 million project to conduct annual iron ore tailings treatment.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares fell 4.8% to $2.80 in pre-market trading after dropping 6% on Wednesday. The company recently announced plans to enter genetic testing market following allowance of U.S. patent for genetic diagnostic test.
Tenax Therapeutics, Inc. (NASDAQ:TENX) shares fell 4% to $2.00 in pre-market trading after gaining around 10% on Wednesday.